8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jan 30, 2020)

Filed January 30, 2020For Securities:DGX

Summary

Quest Diagnostics Inc. (DGX) filed an 8-K on January 30, 2020, to announce its financial results for the fourth quarter and full year ended December 31, 2019. The primary purpose of this filing is to provide investors with an update on the company's performance. The press release attached as an exhibit contains the detailed financial and operational information. Investors should review this press release for specifics regarding revenue, profitability, and any forward-looking statements made by management. This report serves as a crucial update for understanding the company's financial trajectory as of the end of 2019.

Key Highlights

  • 1Quest Diagnostics issued a press release on January 30, 2020, detailing financial results for Q4 and FY 2019.
  • 2The filing incorporates by reference the press release as Exhibit 99.1.
  • 3The press release covers results for the quarter and full year ended December 31, 2019.
  • 4This 8-K filing's main purpose is to disseminate the announced financial and operational results.
  • 5Investors are directed to the attached press release for comprehensive financial details.
  • 6The report includes the standard cover page formatted in Inline XBRL.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce and provide investors with Quest Diagnostics' financial results for the fourth quarter and the full fiscal year ended December 31, 2019, through an attached press release.

The detailed financial results, including revenue, profitability, and other key metrics for the quarter and full year ended December 31, 2019, are located in the press release attached as Exhibit 99.1 to this 8-K filing.

The reported results cover the fourth quarter and the full fiscal year ended December 31, 2019.

While this 8-K itself is primarily an announcement vehicle, the attached press release (Exhibit 99.1) likely contains forward-looking statements made by Quest Diagnostics management regarding future performance and outlook. Investors should carefully review the press release for these statements and associated risks.